Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 229

1.

Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients.

Santamaría C, Muntión S, Rosón B, Blanco B, López-Villar O, Carrancio S, Sánchez-Guijo FM, Díez-Campelo M, Alvarez-Fernández S, Sarasquete ME, de las Rivas J, González M, San Miguel JF, Del Cañizo MC.

Haematologica. 2012 Aug;97(8):1218-24. doi: 10.3324/haematol.2011.054437. Epub 2012 Feb 27.

2.

The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma.

Guo X, Liao Q, Chen P, Li X, Xiong W, Ma J, Li X, Luo Z, Tang H, Deng M, Zheng Y, Wang R, Zhang W, Li G.

J Cancer Res Clin Oncol. 2012 Jan;138(1):49-56. doi: 10.1007/s00432-011-1058-1. Epub 2011 Sep 28.

PMID:
21953080
3.

Down-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells in patients with myelodysplastic syndrome.

Zhao Y, Wu D, Fei C, Guo J, Gu S, Zhu Y, Xu F, Zhang Z, Wu L, Li X, Chang C.

Haematologica. 2015 Feb;100(2):194-204. doi: 10.3324/haematol.2014.109769. Epub 2014 Oct 31.

4.

Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer.

Sand M, Gambichler T, Skrygan M, Sand D, Scola N, Altmeyer P, Bechara FG.

Cancer Invest. 2010 Jul;28(6):649-53. doi: 10.3109/07357901003630918.

PMID:
20210522
5.

DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.

Díaz-García CV, Agudo-López A, Pérez C, López-Martín JA, Rodríguez-Peralto JL, de Castro J, Cortijo A, Martínez-Villanueva M, Iglesias L, García-Carbonero R, Fresno Vara JA, Gámez-Pozo A, Palacios J, Cortés-Funes H, Paz-Ares L, Agulló-Ortuño MT.

Carcinogenesis. 2013 May;34(5):1031-8. doi: 10.1093/carcin/bgt022. Epub 2013 Jan 24.

PMID:
23349018
6.

Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.

Inoue T, Iinuma H, Ogawa E, Inaba T, Fukushima R.

Oncol Rep. 2012 Jun;27(6):1759-64. doi: 10.3892/or.2012.1709. Epub 2012 Mar 7.

PMID:
22407237
7.

Expression analysis of mir-17-5p, mir-20a and let-7a microRNAs and their target proteins in CD34+ bone marrow cells of patients with myelodysplastic syndromes.

Vasilatou D, Papageorgiou SG, Kontsioti F, Kontos CK, Tsiotra P, Mpakou V, Pavlou MA, Economopoulou C, Dimitriadis G, Dervenoulas J, Pappa V.

Leuk Res. 2013 Mar;37(3):251-8. doi: 10.1016/j.leukres.2012.11.011. Epub 2012 Dec 14.

PMID:
23246221
8.

Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma.

Vaksman O, Hetland TE, Trope' CG, Reich R, Davidson B.

Hum Pathol. 2012 Nov;43(11):2062-9. doi: 10.1016/j.humpath.2012.02.016. Epub 2012 May 29.

PMID:
22647351
9.

Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients.

Vincenzi B, Zoccoli A, Schiavon G, Iuliani M, Pantano F, Dell'aquila E, Ratta R, Muda AO, Perrone G, Brunelli C, Correale P, Riva E, Russo A, Loupakis F, Falcone A, Santini D, Tonini G.

Eur J Cancer. 2013 Apr;49(6):1501-8. doi: 10.1016/j.ejca.2012.11.014. Epub 2012 Dec 22.

PMID:
23266047
10.

miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.

Luo Z, Dai Y, Zhang L, Jiang C, Li Z, Yang J, McCarthy JB, She X, Zhang W, Ma J, Xiong W, Wu M, Lu J, Li X, Li X, Xiang J, Li G.

Carcinogenesis. 2013 Feb;34(2):415-25. doi: 10.1093/carcin/bgs329. Epub 2012 Oct 24.

PMID:
23097559
11.

Downregulation of Dicer, a component of the microRNA machinery, in bladder cancer.

Wu D, Tao J, Xu B, Li P, Lu Q, Zhang W.

Mol Med Rep. 2012 Mar;5(3):695-9. doi: 10.3892/mmr.2011.711. Epub 2011 Dec 14.

PMID:
22179432
12.

Expression of the microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung carcinomas.

Prodromaki E, Korpetinou A, Giannopoulou E, Vlotinou E, Chatziathanasiadou Μ, Papachristou NI, Scopa CD, Papadaki H, Kalofonos HP, Papachristou DJ.

Cell Oncol (Dordr). 2015 Aug;38(4):307-17. doi: 10.1007/s13402-015-0231-y. Epub 2015 Jul 31.

PMID:
26227789
13.

Dysregulated expression of dicer and drosha in breast cancer.

Yan M, Huang HY, Wang T, Wan Y, Cui SD, Liu ZZ, Fan QX.

Pathol Oncol Res. 2012 Apr;18(2):343-8. doi: 10.1007/s12253-011-9450-3. Epub 2011 Sep 7.

PMID:
21898071
14.

Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease.

Sharma H, Estep M, Birerdinc A, Afendy A, Moazzez A, Elariny H, Goodman Z, Chandhoke V, Baranova A, Younossi ZM.

J Gastroenterol Hepatol. 2013 Aug;28(8):1410-5. doi: 10.1111/jgh.12268.

PMID:
23663110
15.

miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer.

Li BL, Lu C, Lu W, Yang TT, Qu J, Hong X, Wan XP.

Med Oncol. 2013 Mar;30(1):484. doi: 10.1007/s12032-013-0484-0. Epub 2013 Feb 8.

PMID:
23392577
16.

High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer.

Czubak K, Lewandowska MA, Klonowska K, Roszkowski K, Kowalewski J, Figlerowicz M, Kozlowski P.

Oncotarget. 2015 Sep 15;6(27):23399-416.

17.

A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis.

Tan X, Qin W, Zhang L, Hang J, Li B, Zhang C, Wan J, Zhou F, Shao K, Sun Y, Wu J, Zhang X, Qiu B, Li N, Shi S, Feng X, Zhao S, Wang Z, Zhao X, Chen Z, Mitchelson K, Cheng J, Guo Y, He J.

Clin Cancer Res. 2011 Nov 1;17(21):6802-11. doi: 10.1158/1078-0432.CCR-11-0419. Epub 2011 Sep 2.

18.

VCAM-1 expression on bone marrow stromal cells from patients with myelodysplastic syndromes.

Lubkova ON, Tzvetaeva NV, Momotyuk KS, Belkin VM, Manakova TE.

Bull Exp Biol Med. 2011 May;151(1):13-5.

PMID:
22442792
19.

Gene expression profiling of the bone marrow mononuclear cells from patients with myelodysplastic syndrome.

Qian J, Chen Z, Wang W, Cen J, Xue Y.

Oncol Rep. 2005 Nov;14(5):1189-97.

PMID:
16211284
20.

Downregulated Dicer expression predicts poor prognosis in chronic lymphocytic leukemia.

Zhu DX, Fan L, Lu RN, Fang C, Shen WY, Zou ZJ, Wang YH, Zhu HY, Miao KR, Liu P, Xu W, Li JY.

Cancer Sci. 2012 May;103(5):875-81. doi: 10.1111/j.1349-7006.2012.02234.x. Epub 2012 Mar 15.

Supplemental Content

Support Center